Founded in 2022 in Tel Aviv, Israel, Asterix Foods builds plant cell culture systems designed to overcome the high capital costs and scalability bottlenecks of traditional precision fermentation. Its compact, low-CAPEX bioreactors operate at room temperature, cut energy and water use, and can run multiple production lines to manufacture diverse bioactive proteins year-round with minimal downtime. Because the units are modular and resource-light, facilities can be deployed on non-arable land and co-located with manufacturing hubs to reduce logistics costs and emissions. The company currently runs a pilot facility in central Tel Aviv that showcases this flexible approach. A multidisciplinary team of eight Ph.D.-level researchers in biotechnology and engineering leads product development. With fresh capital, Asterix plans to expand the pilot plant and start sending product samples to select customers, moving toward commercial-scale production.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2025